Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Health Technology Assessment (Winchester, England)|March 8, 2014
Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluationMichael Holmes, John Rathbone, Chris Littlewood, et al.
Pharmacoeconomics|September 22, 2017
Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalIñigo Bermejo, Matt Stevenson, Katy Cooper, et al.
Health Technology Assessment (Winchester, England)|May 17, 2014
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluationJoanna Leaviss, William Sullivan, Shijie Ren, et al.
Health Technology Assessment (Winchester, England)|December 4, 2018
Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviewsRachel Archer, Emma Hock, Jean Hamilton, et al.
Pharmacoeconomics|March 5, 2018
Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMatt Stevenson, Abdullah Pandor, Jean Hamilton, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 28, 2011
BDNF-induced increase of PSD-95 in dendritic spines requires dynamic microtubule invasionsXindao Hu, Lauren Ballo, Lauren Pietila, et al.
Pharmacoeconomics|March 17, 2018
Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology AppraisalLesley Uttley, Iñigo Bermejo, Shijie Ren, et al.
Health Technology Assessment (Winchester, England)|May 2, 2018
What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysisEmma Simpson, Emma Hock, Matt Stevenson, et al.
Pharmacoeconomics|February 27, 2018
Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalAbdullah Pandor, Matt Stevenson, John Stevens, et al.
Rheumatology (Oxford, England)|November 21, 2025
Cost-effectiveness of risk-stratified blood-test monitoring strategies for adults with inflammatory conditionsMatt Stevenson, Georgina Nakafero, Hywel C Williams, et al.
Pageof 7